Amarendra Neppalli to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Amarendra Neppalli has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.173
-
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH. Am J Hematol. 2021 01; 96(1):E5-E8.
Score: 0.142
-
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy. Leukemia. 2019 09; 33(9):2266-2275.
Score: 0.032